ANG Lifesciences India's quarterly market cap
increased
from Jun. 2023 (₹884 Mil) to Sep. 2023 (₹931 Mil) but then
declined
from Sep. 2023 (₹931 Mil) to Dec. 2023 (₹906 Mil).
ANG Lifesciences India's annual market cap
increased
from Mar. 2021 (₹445 Mil) to Mar. 2022 (₹2,432 Mil) but then
declined
from Mar. 2022 (₹2,432 Mil) to Mar. 2023 (₹993 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ANG Lifesciences India's Enterprise Value for Today is ₹1,201 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ANG Lifesciences India's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ANG Lifesciences India's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's Market Cap distribution charts can be found below:
* The bar in red indicates where ANG Lifesciences India's Market Cap falls into.
ANG Lifesciences India Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ANG Lifesciences India's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ANG Lifesciences India (BOM:540694) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ANG Lifesciences India Market Cap Related Terms
Thank you for viewing the detailed overview of ANG Lifesciences India's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
ANG Lifesciences India (BOM:540694) Business Description
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. Geographically, the company carries out sales within India, as well as outside India; generating the majority of revenue from the sales of injections within India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:540694 has been successfully added to your 